[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339839-105":59,"doc-detail-339839-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","in-vitro-biological-evaluation-of-a-novel-folic-acid-targeted-receptor-quantum-dotcyclodextrin-carrier-for-c2028-unsymmetrical-bisacridine-in-the-treatment-of-human-lung-and-prostate-cancers","In vitro biological evaluation of a novel folic acid-targeted receptor quantum dot−β−cyclodextrin carrier for C−2028 unsymmetrical bisacridine in the treatment of human lung and prostate cancers","","Background Traditional small-molecule chemotherapeutics often fail to discriminate tumors from healthy tissues, motivating nanocarrier systems that selectively deliver drugs at the site of action. This study advances the quantum dot−β−cyclodextrin−folic acid (QD−β−CD−FA) platform for targeted delivery of C−2028 unsymmetrical bisacridine. Methods include initial biological evaluation via flow cytometry and light microscopy, plus cell migration analysis in human lung and prostate cancer cells versus corresponding normal cells. Results show C−2028–driven apoptosis stronger in cancer cells, altered senescence dependent on conjugation and FA, and reduced migration by nanoencapsulation, with minimal inherent toxicity.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/in-vitro-biological-evaluation-of-a-novel-folic-acid-targeted-receptor-quantum-dotcyclodextrin-carrier-for-c2028-unsymmetrical-bisacridine-in-the-treatment-of-human-lung-and-prostate-cancers/339839/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/in-vitro-biological-evaluation-of-a-novel-folic-acid-targeted-receptor-quantum-dotcyclodextrin-carrier-for-c2028-unsymmetrical-bisacridine-in-the-treatment-of-human-lung-and-prostate-cancers/339839.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does the study aim to address in cancer chemotherapy?","Question",{"text":113,"@type":114},"Conventional small-molecule chemotherapy does not reliably distinguish tumors from healthy tissues, leading to non-selective toxicity and adverse effects.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which experimental approaches were used for the in vitro evaluation?",{"text":118,"@type":114},"Flow cytometry and light microscopy were used for biological evaluation, alongside cell migration analysis in selected lung and prostate cancer cells and their respective normal cells.",{"name":120,"@type":111,"acceptedAnswer":121},"How did C−2028 and the nanoformulations affect cancer versus normal cells?",{"text":122,"@type":114},"C−2028 induced stronger apoptosis in cancer cells than in normal cells; nanoencapsulation reduced cell migration, and QDgreen or the QDgreen−β−CD−FA conjugate showed no toxic responses in the studied cells.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339839,1790796520,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Pharmacological Reports (2024) 76:823–837  \n[https://doi.org/10.1007/s43440-024-00606-4](https://doi.org/10.1007/s43440-024-00606-4)  \nARTICLE  \nIn vitro biological evaluation of a novel folic acid-targeted receptor quantum dot−β−cyclodextrin carrier for C−2028 unsymmetrical bisacridine in the treatment of human lung and prostate cancers  \nJoanna Pilch1 · Agnieszka Potęga1 · Patrycja Kowalik2 · Agata Kowalczyk3 · Piotr Bujak4 · Artur Kasprzak4 · Ewa Paluszkiewicz1 · Anna Maria Nowicka3  \nReceived: 19 February 2024 / Revised: 21 May 2024 / Accepted: 22 May 2024 / Published online: 18 June 2024 © The Author(s) 2024  \nAbstract  \nBackground Traditional small-molecule chemotherapeutics usually do not distinguish tumors from healthy tissues. However, nanotechnology creates nanocarriers that selectively deliver drugs to their site of action. This work is the next step in the development of the quantum dot−β−cyclodextrin−folic acid (QD−β−CD−FA) platform for targeted and selected delivery ofC−2028 unsymmetrical bisacridine in cancer therapy.  \nMethods Herein, we report an initial biological evaluation (using flow cytometry and light microscopy) as well as cell migration analysis of QD−β−CD(C−2028)−FA nanoconjugate and its components in the selected human lung and prostate cancer cells, as well as against their respective normal cells.  \nResults C−2028 compound induced apoptosis, which was much stronger in cancer cells compared to normal cells. Conjugation of C−2028 with QDgreen increased cellular senescence, while the introduction of FA to the conjugate significantly decreased this process. C−2028 nanoencapsulation also reduced cell migration. Importantly, QDgreen and QDgreen−β−CD − FA themselves did not induce any toxic responses in studied cells.  \nConclusions In conclusion, the results demonstrate the high potential ofa novel folic acid-targeted receptor quantum dot−β − cyclodextrin carrier (QDgreen−β−CD−FA) for drug delivery in cancer treatment. Nanoplatforms increased the amount of delivered compounds and demonstrated high suitability.  \nKeywords Unsymmetrical bisacridine · Folic acid · Targeted cancer therapy · Drug delivery nanosystem · Biological response  \nAbbreviations  \nC−2028 9-{N-[(imidazo[4,5,1-de]-acri  \ndin-6-on-5-yl)aminopropyl]-Nmethylaminopropylamino}-1’-nitroacridine  \n􀀍 Joanna Pilch [joanna.pilch@pg.edu.pl](joanna.pilch@pg.edu.pl)  \n1 Faculty of Chemistry, Gdańsk University of Technology, Narutowicza 11/12 Str., Gdańsk 80-233, Poland  \n2 Institute of Physical Chemistry, Polish Academy of Science, Warsaw, Poland  \n3 Faculty of Chemistry, University of Warsaw, Warsaw, Poland  \n4 Faculty of Chemistry, Warsaw University of Technology, Warsaw, Poland  \nFA  \nFRs  \nFTIRNPs QDs  \nQD−β−CD−FA  \nSA-β-gal TEMTME UA  \nX-gal  \nβ−CD  \nFolic acid  \nFolic acid receptors  \nFourier-transform infrared spectroscopy Nanoparticles  \nQuantum dots, Ag−In−Zn−Snanocrystals  \nQuantum dots−β−cyclodextrin−folic acid (nanoplatforms)  \nSenescence-associated-β-galactosidase Transmission electron microscopy Tumor microenvironment Unsymmetrical bisacridine 5-Bromo-4-chloro-3-indolyl-β-Dgalactosidase  \nβ−Cyclodextrin  \nIntroduction  \nCancers or malignant neoplasms are still a leading cause of morbidity and mortality worldwide [1, 2] . The conventional strategies in cancer treatment involve surgical resection of the solid localized tumors, radiotherapy with X-rays, and chemotherapy used as a single treatment or in combination [3–6]. Although all of them are the most recommended, they are often not enough to provide an effective cure and/or protection from this devastating disease. Chemotherapy, which generally uses small-molecule compounds to kill fast-growing cancer cells and/or delay their growth, is one of the most common methods of treatment for blood-related cancers and solid metastatic tumors [7] . However, the development of a potent anticancer drug is a highly complex and multi-factorial process that faces many difficulties. Drug low water sol","cbCaiqc0BShdJpvn","https://ap.wps.com/l/cbCaiqc0BShdJpvn","pdf",10914207,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Cancer treatment challenges\n## Nanoparticle-based targeted delivery\n## Tumor microenvironment rationale","[{\"question\":\"What problem does the study aim to address in cancer chemotherapy?\",\"answer\":\"Conventional small-molecule chemotherapy does not reliably distinguish tumors from healthy tissues, leading to non-selective toxicity and adverse effects.\"},{\"question\":\"Which experimental approaches were used for the in vitro evaluation?\",\"answer\":\"Flow cytometry and light microscopy were used for biological evaluation, alongside cell migration analysis in selected lung and prostate cancer cells and their respective normal cells.\"},{\"question\":\"How did C−2028 and the nanoformulations affect cancer versus normal cells?\",\"answer\":\"C−2028 induced stronger apoptosis in cancer cells than in normal cells; nanoencapsulation reduced cell migration, and QDgreen or the QDgreen−β−CD−FA conjugate showed no toxic responses in the studied cells.\"}]","In vitro biological evaluation of a novel folic acid-targeted receptor quantum dot−β−cyclodextrin carrier for C−2028 unsymmetrical bisacridine in the treatment of human lung and prostate cancers | PDF",1790032557,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20eb5382ffd665fa5b01b3b5b58fd2ce.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d33a87a8038732f59e38e49362ba6a3.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05e87817a5305e2b2a59b8509fd0f60d.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97edbfb1e10c0463cbdb6f6b02acc23f.webp",980,1301]